Concepts (87)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Leukemia, Myeloid, Acute | 5 | 2025 | 614 | 1.890 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2025 | 236 | 1.350 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2025 | 209 | 0.990 |
Why?
|
| Myosin Heavy Chains | 1 | 2025 | 74 | 0.900 |
Why?
|
| Haploinsufficiency | 1 | 2025 | 266 | 0.810 |
Why?
|
| Cell Cycle Proteins | 1 | 2025 | 710 | 0.670 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2021 | 22 | 0.650 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2021 | 127 | 0.590 |
Why?
|
| Homeodomain Proteins | 1 | 2021 | 555 | 0.520 |
Why?
|
| Immunotherapy | 1 | 2021 | 768 | 0.450 |
Why?
|
| Antibodies, Monoclonal | 1 | 2021 | 981 | 0.430 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 2 | 2024 | 156 | 0.350 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2025 | 30 | 0.230 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2025 | 70 | 0.230 |
Why?
|
| Hydroxyurea | 1 | 2024 | 89 | 0.200 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2024 | 176 | 0.190 |
Why?
|
| Afibrinogenemia | 1 | 2021 | 12 | 0.170 |
Why?
|
| Anemia, Sickle Cell | 1 | 2024 | 334 | 0.160 |
Why?
|
| Burkitt Lymphoma | 1 | 2021 | 131 | 0.160 |
Why?
|
| Fibrinogen | 1 | 2021 | 170 | 0.160 |
Why?
|
| Anaphylaxis | 1 | 2021 | 94 | 0.150 |
Why?
|
| Hypersensitivity | 1 | 2021 | 227 | 0.140 |
Why?
|
| Proportional Hazards Models | 1 | 2021 | 1410 | 0.130 |
Why?
|
| Disease Models, Animal | 2 | 2025 | 4697 | 0.130 |
Why?
|
| DNA-Binding Proteins | 1 | 2025 | 1939 | 0.130 |
Why?
|
| Mice | 5 | 2025 | 18301 | 0.130 |
Why?
|
| Prognosis | 3 | 2021 | 4886 | 0.120 |
Why?
|
| Skin Diseases, Bacterial | 1 | 2016 | 22 | 0.120 |
Why?
|
| Soft Tissue Infections | 1 | 2016 | 90 | 0.110 |
Why?
|
| Intellectual Disability | 1 | 2022 | 1089 | 0.110 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2023 | 1280 | 0.110 |
Why?
|
| Child | 5 | 2024 | 26341 | 0.100 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2021 | 895 | 0.100 |
Why?
|
| Animals | 6 | 2025 | 33912 | 0.100 |
Why?
|
| Phenotype | 1 | 2021 | 4497 | 0.090 |
Why?
|
| Genomics | 1 | 2020 | 1621 | 0.090 |
Why?
|
| Hematopoiesis | 2 | 2023 | 213 | 0.080 |
Why?
|
| Hospitals, Pediatric | 1 | 2016 | 808 | 0.080 |
Why?
|
| Humans | 9 | 2024 | 131163 | 0.080 |
Why?
|
| Epithelial Sodium Channels | 1 | 2009 | 15 | 0.080 |
Why?
|
| Quality Improvement | 1 | 2016 | 722 | 0.070 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2016 | 789 | 0.070 |
Why?
|
| Protons | 1 | 2009 | 94 | 0.070 |
Why?
|
| Sodium Channels | 1 | 2009 | 97 | 0.070 |
Why?
|
| Adolescent | 3 | 2024 | 20987 | 0.070 |
Why?
|
| Protein Isoforms | 1 | 2009 | 423 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 688 | 0.060 |
Why?
|
| Antisickling Agents | 1 | 2024 | 20 | 0.050 |
Why?
|
| Splenic Diseases | 1 | 2024 | 28 | 0.050 |
Why?
|
| Calcium | 1 | 2009 | 1010 | 0.050 |
Why?
|
| Splenomegaly | 1 | 2024 | 32 | 0.050 |
Why?
|
| Splenectomy | 1 | 2024 | 61 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 2596 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2009 | 1075 | 0.050 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 1 | 2023 | 52 | 0.050 |
Why?
|
| Ikaros Transcription Factor | 1 | 2021 | 34 | 0.040 |
Why?
|
| Germ Cells | 1 | 2022 | 201 | 0.040 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2023 | 544 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2024 | 2326 | 0.040 |
Why?
|
| Recurrence | 1 | 2021 | 1489 | 0.030 |
Why?
|
| Prevalence | 1 | 2024 | 2701 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2024 | 3819 | 0.030 |
Why?
|
| Ohio | 1 | 2016 | 85 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2023 | 1928 | 0.030 |
Why?
|
| Infant | 2 | 2024 | 13352 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2024 | 15110 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2016 | 732 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2023 | 4738 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2016 | 447 | 0.030 |
Why?
|
| Degenerin Sodium Channels | 1 | 2009 | 2 | 0.020 |
Why?
|
| Spider Venoms | 1 | 2009 | 6 | 0.020 |
Why?
|
| Acid Sensing Ion Channels | 1 | 2009 | 4 | 0.020 |
Why?
|
| Female | 3 | 2024 | 70963 | 0.020 |
Why?
|
| Xenopus laevis | 1 | 2009 | 112 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2009 | 300 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2009 | 271 | 0.020 |
Why?
|
| Point Mutation | 1 | 2009 | 333 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 716 | 0.020 |
Why?
|
| Oocytes | 1 | 2009 | 283 | 0.020 |
Why?
|
| Mutation | 1 | 2021 | 6099 | 0.020 |
Why?
|
| Hospitalization | 1 | 2016 | 1950 | 0.020 |
Why?
|
| Peptides | 1 | 2009 | 708 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2024 | 17753 | 0.010 |
Why?
|
| Time Factors | 1 | 2016 | 6196 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 2395 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 3464 | 0.010 |
Why?
|
| Male | 2 | 2024 | 64957 | 0.010 |
Why?
|